Equities

Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc

Actions
  • Price (USD)4.89
  • Today's Change-0.182 / -3.58%
  • Shares traded923.00
  • 1 Year change+11.49%
  • Beta--
Data delayed at least 20 minutes, as of Nov 14 2024 15:34 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments145253401
Total Receivables, Net2.41128.03
Total Inventory------
Prepaid expenses5.415139
Other current assets, total------
Total current assets153315448
Property, plant & equipment, net141829
Goodwill, net01111
Intangibles, net02.132.63
Long term investments2.782.013.91
Note receivable - long term------
Other long term assets0.610.681.43
Total assets171349496
LIABILITIES
Accounts payable3.582024
Accrued expenses212936
Notes payable/short-term debt000
Current portion long-term debt/capital leases17----
Other current liabilities, total0.112.564.62
Total current liabilities439766
Total long term debt01715
Total debt171715
Deferred income tax00.030.03
Minority interest------
Other liabilities, total111316
Total liabilities5412696
SHAREHOLDERS EQUITY
Common stock0.020.250.22
Additional paid-in capital1,7411,7111,610
Retained earnings (accumulated deficit)(1623)(1488)(1210)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.66)(0.7)(0.28)
Total equity117222400
Total liabilities & shareholders' equity171349496
Total common shares outstanding232118
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.